Unparalleled Cannabis Data Aggregator

Mainstreaming Medical Cannabis Into Traditional Healthcare

“CB2 Insights as a data aggregator within the medical cannabis space. Data that’s more traditionally found within healthcare settings and information that we collect through our own data assets focused out of the US.

We have our own assets of medical clinics it’s about 28 clinics in twelve states and we just recently announced an acquisition for two more states. The future of the industry as it evolves into better education and knowledge, we expect that CB2 Insights will be a primer for data to power that industry.” CB2 Insights CEO, Prad Sekar

CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare.

Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry. To date, the Company has collected millions of data points from more than 300,000 patient interactions.

For more information on CB2 Insights (CBII: CSE) please fill out the form below.

Request Investor Kit

Name*

Email*

*Required.